Results 21 to 30 of about 2,106 (208)

Underactive Bladder Syndrome: An Often Overlooked Condition [PDF]

open access: yes, 2021
Urinary bladder outlet obstruction can cause lower urinary tract symptoms in men and women, such as a weak or interrupted urine stream, straining to void, hesitancy, and the feeling of incomplete bladder emptying.
Ivan Radoja
core   +2 more sources

Evaluation of responses to 5-HT-enhancing drugs in NMRI mice [PDF]

open access: yes, 2015
In humans, the ingestion of the combination of two or more serotonin (5-HT)-enhancing drugs but also of a single drug in overdose can induce serious adverse effects, which are characteristics of the serotonin syndrome (SS).
Bert, Bettina   +2 more
core   +1 more source

Neuroscience in peripheral cancers: tumors hijacking nerves and neuroimmune crosstalk. [PDF]

open access: yesMedComm (2020)
The figure depicts the intricate interactions between cancer cells, the immune system, and nerves within the tumor microenvironment. At the center, the diagram highlights the tripartite relationship among cancer, immune, and nerve cells, illustrating the dynamic and reciprocal influences they exert on one another.
Fan HY, Liang XH, Tang YL.
europepmc   +2 more sources

Treatment Strategy According to Findings on Pressure-Flow Study for Women with Decreased Urinary Flow Rate [PDF]

open access: yes, 2009
Purpose. In women who reported a weak urinary stream, the efficacy of treatment chosen according to the urodynamic findings on pressure-flow study was prospectively evaluated. Materials and Methods.
Furuya, Ryoji   +5 more
core   +3 more sources

Differential activity and clinical utility of latanoprost in glaucoma and ocular hypertension [PDF]

open access: yes, 2012
Background: The purpose of this study was to demonstrate the hypotensive efficacy and tolerability of latanoprost when used as monotherapy and as polytherapy associated with antiglaucomatous medication proven to be ineffective in keeping intraocular ...
Brillante, Chiara   +9 more
core   +2 more sources

Prescription Patterns and Cost Effectiveness of Antiglaucoma Drugs in a Tertiary Hospital in Nigeria [PDF]

open access: yes, 2020
This study sought to determine the prescribing patterns and designed a treatment guideline for primary open-angle glaucoma (POAG) that is more cost-effective from a third-party payer’s perspective than the current practice based on real-world evidence. A
Udezi, W.A., Usifoh, S.F.
core   +1 more source

Management of Glaucoma in Pregnancy [PDF]

open access: yes, 2019
Management of glaucoma during pregnancy represents a challenge for the physician. Important disease and patient health decisions begin even prior to conception and continue throughout pregnancy and breastfeeding.
  +97 more
core   +1 more source

Effects of Omidenepag Isopropyl Versus Latanoprost Eye Drops on Intraocular Pressure, Pupil Diameter, and Anterior Chamber Parameters in Normal Feline Eyes: A Pilot Study

open access: yesVeterinary Ophthalmology, EarlyView.
ABSTRACT Objectives This study aimed to compare the effect of the newly developed selective prostaglandin E2 receptor agonist, omidenepag isopropyl (OMDI), and latanoprost on intraocular pressure (IOP), pupil diameter (PD), and anterior chamber parameters in normal feline eyes.
Sang‐Eun Park   +5 more
wiley   +1 more source

Informetrics on accidents and trauma [PDF]

open access: yes, 1998
MEDLINE database has been analysed for 1995-97 on index Accidents and Trauma. Publications output has been classified year-wise country-wise, journal-wise and other fine structure characteristics have been found.
Kadam, S. N., Kalyane, V. L.
core  

Efficacy and safety of abatacept in active primary Sjogren's syndrome:results of a phase III, randomised, placebo-controlled trial [PDF]

open access: yes, 2021
Objectives To evaluate efficacy and safety of abatacept in adults with active primary Sjogren's syndrome (pSS) in a phase III, randomised, double-blind, placebo-controlled trial. Methods Eligible patients (moderate-to-severe pSS [2016 ACR/European League
Baer, Alan N.   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy